A systematic review of the use of atomoxetine for management of comorbid anxiety disorders in children and adolescents with attention-deficit hyperactivity disorder.
All,
This review found that atomoxetine, a non-stimulant ADHD medication, may also help reduce anxiety symptoms in children and adolescents with ADHD — which is relevant for many families affected by 16p11.2 syndromes where both ADHD and anxiety commonly co-occur.